Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hesham Elhalawani, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed ASR, Fuller CD, Lai SY, Rao A. Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients. Front Artif Intell. 2021; 4:618469. PMID: 33898983.
    Citations:    
  2. Al Feghali KA, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C. Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status. Neurooncol Pract. 2021 Apr; 8(2):199-208. PMID: 33898053.
    Citations:    
  3. Elhalawani H, Mohamed ASR, Elgohari B, Lin TA, Sikora AG, Lai SY, Abusaif A, Phan J, Morrison WH, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Sandulache VC. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020 Sep 23; 20(1):912. PMID: 32967643.
    Citations:    Fields:    
  4. McCulloch MM, Cazoulat G, Ford AC, Elgohari B, Bahig H, Kim AD, Elhalawani H, He R, Wang J, Ding Y, Mohamed AS, Polan DF, King JB, Peterson CB, Ohrt AN, Fuller CD, Lai SY, Brock KK. Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration. Phys Med Biol. 2020 08 31; 65(16):165017. PMID: 32320955.
    Citations:    Fields:    Translation:Humans
  5. Kiser KJ, Ahmed S, Stieb S, Mohamed ASR, Elhalawani H, Park PYS, Doyle NS, Wang BJ, Barman A, Li Z, Zheng WJ, Fuller CD, Giancardo L. PleThora: Pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelines. Med Phys. 2020 Nov; 47(11):5941-5952. PMID: 32749075.
    Citations: 1     Fields:    
  6. Mohamed ASR, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Kim AD, Ahmed H, Garcia JA, Johnson JM, Stafford RJ, Bankson JA, Chambers MS, Sandulache VC, Fuller CD, Lai SY. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1319-1328. PMID: 32712257.
    Citations:    Fields:    Translation:HumansPHPublic Health
  7. Kundu S, Elhalawani H, Gichoya JW, Kahn CE. How Might AI and Chest Imaging Help Unravel COVID-19's Mysteries? Radiol Artif Intell. 2020 May; 2(3):e200053. PMID: 33928254.
    Citations:    
  8. Ng SP, Cardenas CE, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson JM, Kamal M, Garden AS, Reddy JP, Su SY, Ferrarotto R, Frank SJ, Brandon Gunn G, Moreno AC, Rosenthal DI, Fuller CD, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Phys Imaging Radiat Oncol. 2020 Apr; 14:1-5. PMID: 33458306.
    Citations:    
  9. Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Sci Rep. 2020 03 18; 10(1):4926. PMID: 32188907.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  10. Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O'Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, Gazzani SE, Calareso G, Scheckenbach K, Hoebers F, Wesseling FWR, Keek S, Sanduleanu S, Leijenaar RTH, Vergeer MR, Leemans CR, Terhaard CHJ, van den Brekel MWM, Hamming-Vrieze O, van der Heijden MA, Elhalawani HM, Fuller CD, Guckenberger M, Lambin P. Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Sci Rep. 2020 03 11; 10(1):4542. PMID: 32161279.
    Citations: 5     Fields:    Translation:HumansCells
  11. He R, Ding Y, Mohamed ASR, Ng SP, Ger RB, Elhalawani H, Elgohari BA, Young KH, Hutcheson KA, Fuller CD, Lai SY. Simultaneously spatial and temporal Higher-Order Total Variations for noise suppression and motion reduction in DCE and IVIM. Proc SPIE Int Soc Opt Eng. 2020 Feb; 11313. PMID: 32753776.
    Citations:    
  12. Tosado J, Zdilar L, Elhalawani H, Elgohari B, Vock DM, Marai GE, Fuller C, Mohamed ASR, Canahuate G. Clustering of Largely Right-Censored Oropharyngeal Head and Neck Cancer Patients for Discriminative Groupings to Improve Outcome Prediction. Sci Rep. 2020 03 02; 10(1):3811. PMID: 32123193.
    Citations: 1     Fields:    Translation:Humans
  13. Jin Y, Randall JW, Elhalawani H, Feghali KAA, Elliott AM, Anderson BM, Lacerda L, Tran BL, Mohamed AS, Brock KK, Fuller CD, Chung C. Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging. Cancers (Basel). 2020 Feb 29; 12(3). PMID: 32121471.
    Citations: 1     
  14. Elhalawani H, Awan MJ, Ding Y, Mohamed ASR, Elsayes AK, Abu-Gheida I, Wang J, Hazle J, Gunn GB, Lai SY, Frank SJ, Ginsberg LE, Rosenthal DI, Fuller CD. Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. Sci Data. 2020 02 21; 7(1):63. PMID: 32081849.
    Citations:    Fields:    Translation:Humans
  15. Elhalawani H, Yang P, Abazeed M, Shah C, Mohamed ASR, Thomas CR, Fuller CD, Thompson RF. Real-world applications of deep convolutional neural networks in diagnostic cancer imaging. Chin Clin Oncol. 2020 Dec; 9(6):82. PMID: 32036673.
    Citations:    Fields:    
  16. Ng SP, Bahig H, Jethanandani A, Pollard C, Berends J, Sturgis EM, Johnson FM, Elgohari B, Elhalawani H, Rosenthal DI, Skinner HD, Gunn GB, Phan J, Frank SJ, Mohamed ASR, Fuller CD, Garden AS. Lymphopenia during radiotherapy in patients with oropharyngeal cancer. Radiother Oncol. 2020 04; 145:95-100. PMID: 31931292.
    Citations:    Fields:    Translation:HumansCells
  17. Liu R, Elhalawani H, Radwan Mohamed AS, Elgohari B, Court L, Zhu H, Fuller CD. Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer. Clin Transl Radiat Oncol. 2020 Mar; 21:11-18. PMID: 31886423.
    Citations: 2     
  18. Stieb S, Kiser K, van Dijk L, Livingstone NR, Elhalawani H, Elgohari B, McDonald B, Ventura J, Mohamed ASR, Fuller CD. Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques. Hematol Oncol Clin North Am. 2020 02; 34(1):293-306. PMID: 31739950.
    Citations:    Fields:    Translation:Humans
  19. Rhee DJ, Cardenas CE, Elhalawani H, McCarroll R, Zhang L, Yang J, Garden AS, Peterson CB, Beadle BM, Court LE. Automatic detection of contouring errors using convolutional neural networks. Med Phys. 2019 Nov; 46(11):5086-5097. PMID: 31505046.
    Citations: 7     Fields:    Translation:Humans
  20. Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J, Fuller CD, Li H, Howell RM, Layman RR, Mawlawi O, Stafford RJ, Aerts H, Court LE. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients. PLoS One. 2019; 14(9):e0222509. PMID: 31536526.
    Citations: 11     Fields:    Translation:Humans
  21. McCulloch MM, Anderson BM, Cazoulat G, Peterson CB, Mohamed ASR, Volpe S, Elhalawani H, Bahig H, Rigaud B, King JB, Ford AC, Fuller CD, Brock KK. Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer images. Phys Med Biol. 2019 09 05; 64(17):175018. PMID: 31269475.
    Citations:    Fields:    Translation:Humans
  22. Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation. Radiother Oncol. 2020 01; 142:100-106. PMID: 31431381.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  23. Elhalawani H, Fuller CD, Thompson RF. The Potential and Pitfalls of Crowdsourced Algorithm Development in Radiation Oncology. JAMA Oncol. 2019 05 01; 5(5):662-663. PMID: 30998812.
    Citations: 1     Fields:    Translation:Humans
  24. Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD. Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients. Clin Transl Radiat Oncol. 2019 Sep; 18:120-127. PMID: 31341987.
    Citations: 6     
  25. Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep. 2019 02 04; 9(1):1322. PMID: 30718585.
    Citations: 4     Fields:    Translation:HumansCells
  26. Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive. JCO Clin Cancer Inform. 2019 02; 3:1-9. PMID: 30730765.
    Citations: 9     Fields:    Translation:Humans
  27. Lin TA, Garden AS, Elhalawani H, Elgohari B, Jethanandani A, Ng SP, Mohamed AS, Frank SJ, Glisson BS, Debnam JM, Sturgis EM, Phan J, Reddy JP, Fuller CD, Morrison WH, Skinner HD, Rosenthal DI, Gunn GB. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Cancer. 2019 05 01; 125(9):1536-1546. PMID: 30620385.
    Citations: 4     Fields:    Translation:Humans
  28. Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR, Okunieff P, Fuller CD. An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. Clin Transl Radiat Oncol. 2019 Feb; 15:83-92. PMID: 30775563.
    Citations:    
  29. Zdilar L, Vock DM, Marai GE, Fuller CD, Mohamed ASR, Elhalawani H, Elgohari BA, Tiras C, Miller A, Canahuate G. Evaluating the Effect of Right-Censored End Point Transformation for Radiomic Feature Selection of Data From Patients With Oropharyngeal Cancer. JCO Clin Cancer Inform. 2018 12; 2:1-19. PMID: 30652615.
    Citations: 3     Fields:    Translation:Humans
  30. Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data. 2018 11 27; 5(1):1. PMID: 30482902.
    Citations: 1     Fields:    
  31. Cardenas CE, Anderson BM, Aristophanous M, Yang J, Rhee DJ, McCarroll RE, Mohamed ASR, Kamal M, Elgohari BA, Elhalawani HM, Fuller CD, Rao A, Garden AS, Court LE. Auto-delineation of oropharyngeal clinical target volumes using 3D convolutional neural networks. Phys Med Biol. 2018 11 07; 63(21):215026. PMID: 30403188.
    Citations: 6     Fields:    Translation:Humans
  32. Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE. Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph. 2018 11; 69:134-139. PMID: 30268005.
    Citations: 8     Fields:    Translation:Humans
  33. Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data. 2018 09 04; 5:180173. PMID: 30179230.
    Citations: 9     Fields:    Translation:Humans
  34. Yang P, Xu T, Gomez DR, Deng W, Wei X, Elhalawani H, Jin H, Guan F, Mirkovic D, Xu Y, Mohan R, Liao Z. Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):123-131. PMID: 30165127.
    Citations: 6     Fields:    Translation:Humans
  35. Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD. Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges. Front Oncol. 2018; 8:294. PMID: 30175071.
    Citations: 6     
  36. Abdel-Rahman O, Elhalawani HM, Allen PK, Holliday EB. Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):611-620. PMID: 30370362.
    Citations: 1     
  37. Holliday EB, Allen PK, Elhalawani H, Abdel-Rahman O. Outcomes of patients in the national cancer database treated non-surgically for localized rectal cancer. J Gastrointest Oncol. 2018 Aug; 9(4):589-600. PMID: 30151255.
    Citations:    
  38. Jethanandani A, Lin TA, Volpe S, Elhalawani H, Mohamed ASR, Yang P, Fuller CD. Exploring Applications of Radiomics in Magnetic Resonance Imaging of Head and Neck Cancer: A Systematic Review. Front Oncol. 2018; 8:131. PMID: 29868465.
    Citations: 18     
  39. Abdel-Rahman O, Elsayed Z, Elhalawani H. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database Syst Rev. 2018 Apr 06; 4:CD011746. PMID: 29624208.
    Citations: 13     Fields:    Translation:Humans
  40. Cardenas CE, McCarroll RE, Court LE, Elgohari BA, Elhalawani H, Fuller CD, Kamal MJ, Meheissen MAM, Mohamed ASR, Rao A, Williams B, Wong A, Yang J, Aristophanous M. Deep Learning Algorithm for Auto-Delineation of High-Risk Oropharyngeal Clinical Target Volumes With Built-In Dice Similarity Coefficient Parameter Optimization Function. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):468-478. PMID: 29559291.
    Citations: 20     Fields:    Translation:Humans
  41. Holliday EB, Allen PK, Elhalawani H, Abdel-Rahman O. Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma. Liver Int. 2018 04; 38(4):665-675. PMID: 28853231.
    Citations: 1     Fields:    Translation:Humans
  42. Yang P, Elhalawani H, Shi Y, Tang Y, Han Y, Zhao Y, Lou F, Jin H. A large-scale retrospective study of the overall survival outcome in nasopharyngeal carcinoma with hypertension in Chinese population. Oncotarget. 2017 Sep 26; 8(43):75577-75586. PMID: 29088892.
    Citations: 1     Fields:    
  43. Yang P, Deng W, Han Y, Shi Y, Xu T, Shi J, Elhalawani H, Zhao Y, Xie X, Lou F, Zhang R, Jin H. Analysis of the correlation among hypertension, the intake of ß-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancer. Am J Cancer Res. 2017; 7(4):946-954. PMID: 28469966.
    Citations: 5     
  44. Elhalawani H, Heiba M, Abdel-Rahman O. Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta-analysis. Clin Genitourin Cancer. 2017 06; 15(3):e325-e335. PMID: 28189432.
    Citations:    Fields:    Translation:Humans
  45. Abdel-Rahman O, Bahie Eldin N, ElHalawani H. Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib: a meta-analysis. Future Oncol. 2016 Sep; 12(18):2163-72. PMID: 27301454.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  46. Abdel-Rahman O, ElHalawani H. Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agents. Crit Rev Oncol Hematol. 2016 Jun; 102:89-100. PMID: 27129437.
    Citations: 2     Fields:    Translation:Humans
  47. Abdel-Rahman O, ElHalawani H, Essam-Eldin S. S-1-based regimens and the risk of leucopenic complications; a Meta-analysis with comparison to other fluoropyrimidines and non fluoropyrimidines. Expert Opin Drug Saf. 2016; 15(4):437-48. PMID: 26811188.
    Citations:    Fields:    Translation:Humans
  48. Abdel-Rahman O, ElHalawani H. S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer: a meta-analysis. Future Oncol. 2016 Mar; 12(5):701-13. PMID: 26838139.
    Citations:    Fields:    Translation:Humans
  49. Abdel-Rahman O, ElHalawani H, Fouad M. Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis. Future Oncol. 2016 Feb; 12(3):413-25. PMID: 26775673.
    Citations: 27     Fields:    Translation:Humans
  50. Abdel-Rahman O, Ahmed H, ElHalawani H. Risk of elevated transaminases in non-small cell lung cancer (NSCLC) patients treated with erlotinib, gefitinib and afatinib: a meta-analysis. Expert Rev Respir Med. 2016 Feb; 10(2):223-34. PMID: 26558417.
    Citations:    Fields:    Translation:Humans
  51. Abdel-Rahman O, ElHalawani H, Ahmed H. Risk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis. J Glob Oncol. 2015 Dec; 1(2):73-82. PMID: 28804776.
    Citations: 8     Fields:    
  52. Abdel-Rahman O, ElHalawani H, Ahmed H. Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis. Future Oncol. 2015; 11(24):3307-19. PMID: 26561878.
    Citations: 4     Fields:    Translation:Humans
  53. Abdel-Rahman O, ElHalawani H, Essam-Eldin S. S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines. Expert Opin Drug Saf. 2016 Jan; 15(1):5-20. PMID: 26513339.
    Citations: 4     Fields:    Translation:Humans
  54. Abdel-Rahman O, ElHalawani H, Fouad M. Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Immunotherapy. 2015; 7(11):1213-27. PMID: 26513491.
    Citations: 20     Fields:    Translation:Humans
  55. Abdel-Rahman O, ElHalawani H. Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis. Future Oncol. 2015; 11(21):2949-61. PMID: 26422782.
    Citations: 2     Fields:    Translation:Humans
  56. Abdel-Rahman O, ElHalawani H, Ahmed H, Ellithy M. Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2015; 9(11):1433-45. PMID: 26365425.
    Citations: 4     Fields:    Translation:HumansCells
  57. Abdel-Rahman O, ElHalawani H, Fouad M. Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Expert Opin Drug Saf. 2015 Oct; 14(10):1507-18. PMID: 26394770.
    Citations: 18     Fields:    Translation:Humans
  58. Abdel-Rahman O, ElHalawani H. Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis. Expert Opin Drug Saf. 2015 Oct; 14(10):1495-506. PMID: 26313327.
    Citations: 3     Fields:    Translation:Humans
  59. Abdel-Rahman O, ElHalawani H. Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-Analysis. Chemotherapy. 2014; 60(5-6):325-33. PMID: 26302785.
    Citations: 5     Fields:    Translation:Humans
  60. Abdel-Rahman O, ElHalawani H, Fouad M. Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis. Future Oncol. 2015; 11(17):2471-84. PMID: 26274495.
    Citations: 16     Fields:    Translation:Humans
  61. ElHalawani H, Abdel-Rahman O. Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers. Ther Clin Risk Manag. 2015; 11:1123-32. PMID: 26251608.
    Citations: 1     
  62. Abdel-Rahman O, Elhalawani H. Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis. Future Oncol. 2015; 11(7):1109-22. PMID: 25804125.
    Citations: 3     Fields:    Translation:Humans
  63. Abdel-Rahman O, ElHalawani H. Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns. Expert Opin Drug Saf. 2014 Nov; 13(11):1443-67. PMID: 25244502.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Elhalawani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (167)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.